Aspirin Responsiveness in Women With Coronary Artery Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01406990|
Recruitment Status : Completed
First Posted : August 1, 2011
Results First Posted : September 28, 2012
Last Update Posted : September 28, 2012
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||15 participants|
|Official Title:||Aspirin Responsiveness in Women With Coronary Artery Disease|
|Study Start Date :||June 2011|
|Actual Primary Completion Date :||April 2012|
|Actual Study Completion Date :||April 2012|
Aspirin 81 mg
Women with CAD taking 81 mg aspirin.
- Women With Known CAD Who Are Hyporesponsive to Low Dose (81 mg) Aspirin [ Time Frame: Time of enrollment ]Hyporesponsive was defined as Aspirin Response Unit (ARU) > 550 equating to less than 50% platelet inhibition.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01406990
|United States, Nebraska|
|The Cardiac Center at Creighton University|
|Omaha, Nebraska, United States, 68131|
|Principal Investigator:||Katie Packard, PharmD||Creighton University|